Walleye Capital’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32.6K	Sell	11,900 -147,800	-93%	-$468K	﹤0.01%	3995
2025 Q4	$591K	Buy	159,700 +86,900	+119%	+$281K	﹤0.01%	2852
2025 Q3	$193K	Buy	+72,800	New	+$141K	﹤0.01%	3338
2025 Q1	–	Sell	-8,700	Closed	-$19.1K	–	4474
2024 Q4	$19.1K	Buy	+8,700	New	+$20.3K	﹤0.01%	4508
2023 Q2	–	Sell	-6,300	Closed	-$10K	–	4463
2023 Q1	$10K	Buy	+6,300	New	+$32.5K	﹤0.01%	3547
2022 Q4	–	Sell	-10,800	Closed	-$72K	–	3304
2022 Q3	$72K	Buy	+10,800	New	+$74.2K	﹤0.01%	2515
2020 Q1	–	Sell	-29,200	Closed	-$1.74M	–	1146
2019 Q4	$1.74M	Sell	29,200 -27,300	-48%	-$1.23M	0.11%	243
2019 Q3	$2.07M	Buy	56,500 +53,100	+1,562%	+$2.1M	0.12%	212
2019 Q2	$158K	Sell	3,400 -11,000	-76%	-$517K	0.02%	1056
2019 Q1	$578K	Buy	+14,400	New	+$646K	0.1%	336